The company offers an automated benchtop immunoassay platform that replaces conventional ELISA with a microfluidic gel‑based system performing on‑cartridge electrophoretic separation. It delivers quantitative protein measurements from 1 µL samples in approximately 60 minutes, with a six‑log dynamic range, picogram‑per‑milliliter sensitivity, and ~10 % coefficient of variation, supporting standard and custom assay kits for biopharma R&D.
Funding
$9.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional ELISA workflows require bulky equipment, extensive manual handling, and relatively large sample volumes, resulting in long assay times, high variability, and limited throughput for protein quantification in research and development settings.
Solution
The PIXI platform delivers an automated benchtop immunoassay system that replaces traditional ELISA with a microfluidic gel‑based approach. By integrating hands‑free liquid handling and on‑cartridge electrophoretic separation, the system generates quantitative protein data in approximately 60 minutes with a coefficient of variation around 10 %. Its microfluidic design reduces required sample input to as little as 1 µL while maintaining a six‑log dynamic range and picogram‑per‑milliliter sensitivity. The platform supports standard assay kits for biopharmaceutical analysis, cell‑ and gene‑therapy studies, and synthetic biology, and can be extended with custom assay development. Results are exported via secure cloud or local interfaces for downstream analysis, enabling faster decision‑making without sacrificing data quality.
Target Audience
Primary customers are R&D laboratories in biopharmaceutical companies, cell‑ and gene‑therapy developers, and synthetic‑biology research groups that require high‑precision, low‑volume protein quantification.
Features
- Proprietary microfluidic gel technology that performs electrophoretic separation and detection within a single cartridge
- Fully automated, hands‑free workflow delivering reproducible results (≈10 % CV) with minimal operator intervention
- Ultra‑low sample requirement of 1 µL, preserving precious biospecimens
- Six‑log dynamic range allowing simultaneous quantification of high‑ and low‑abundance proteins in a single dilution step
- Rapid sample‑to‑data turnaround of ~60 minutes per run
- Scalable throughput: cartridges accommodate 32 to 96 samples, suitable for mid‑scale screening campaigns
- High sensitivity detection down to pg/mL concentrations for low‑level biomarker analysis
- Compatibility with existing laboratory automation platforms and data management systems via API/standard file export